FDA tells drugmakers to redo studies run by a contract research firm due to data integrity issues

What's new in pharma

April 4, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

STAT+ | FDA tells drugmakers to redo studies run by a contract research firm due to data integrity issues Citing "objectionable conditions," the agency said there were problems with the way Raptim Research tested medicines in India. By Ed Silverman STAT+ | Federal advisory panel on ethical, legal issues in human health research disbanded The Secretary's Advisory Committee on Human Research Protections was an 11-member panel of volunteers with expertise in bioethics and regulatory affairs. By Megan Molteni and Ed Silverman NIH hit with chaos, cuts, and contractor purge Today's biotech news covers NIH budget slashes by DOGE, a U.K. drug pricing scheme facing backlash, and more. By Meghana Keshavan Ben Gray/AP Federal judge says she will temporarily block billions in health funding cuts to states U.S. District Judge Mary McElroy in Rhode Island said she plans to grant the court order sought by 23 states and the District of Columbia. By Associated Press

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser